company background image
BIOC logo

GlaxoSmithKlineE CASE:BIOC Stock Report

Last Price

ج.م37.38

Market Cap

ج.م3.1b

7D

0.4%

1Y

9.3%

Updated

15 Apr, 2025

Data

Company Financials

GlaxoSmithKline S.A.E

CASE:BIOC Stock Report

Market Cap: ج.م3.1b

BIOC Stock Overview

Engages in production of pharmaceutical chemicals. More details

BIOC fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends1/6

Rewards

Earnings grew by 187.8% over the past year

Risk Analysis

Earnings have declined by 12.3% per year over past 5 years

High level of non-cash earnings

Does not have a meaningful market cap (EGP3B)


GlaxoSmithKline S.A.E Competitors

Kahira Pharmaceuticals & Chemical Industries

CASE:CPCI

ج.م2.3b

Alexandria For Pharmaceuticals & Chemical Industries

CASE:AXPH

ج.م2.1b

Memphis Pharmaceuticals & Chemical Industries

CASE:MPCI

ج.م1.7b

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E

CASE:RMDA

ج.م6.7b

Price History & Performance

Summary of share price highs, lows and changes for GlaxoSmithKlineE
Historical stock prices
Current Share Priceج.م37.38
52 Week Highج.م47.30
52 Week Lowج.م24.70
Beta0.95
1 Month Change-6.13%
3 Month Change0.65%
1 Year Change9.33%
3 Year Change62.31%
5 Year Change313.50%
Change since IPO301.07%

Recent News & Updates

Recent updates

Shareholder Returns

BIOCEG PharmaceuticalsEG Market
7D0.4%1.8%0.7%
1Y9.3%22.6%10.5%

Return vs Industry: BIOC underperformed the EG Pharmaceuticals industry which returned 24.8% over the past year.

Return vs Market: BIOC matched the EG Market which returned 9.8% over the past year.

Price Volatility

Is BIOC's price volatile compared to industry and market?
BIOC volatility
BIOC Average Weekly Movement4.2%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement4.9%
10% most volatile stocks in EG Market8.2%
10% least volatile stocks in EG Market2.8%

Stable Share Price: BIOC has not had significant price volatility in the past 3 months compared to the EG market.

Volatility Over Time: BIOC's weekly volatility (4%) has been stable over the past year.

Community vs My Fair Value

Select a narrative for quick price alerts from the community, or create your own.

About the Company

FoundedEmployeesCEOWebsite
1981n/aHassan Fahmiwww.gsk.com/en-gb/contact-us/worldwide/egypt

GlaxoSmithKline S.A.E. engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E. was founded in 1981 and is based in London, the United Kingdom.

GlaxoSmithKline S.A.E Fundamentals Summary

How do GlaxoSmithKlineE's earnings and revenue compare to its market cap?
BIOC fundamental statistics
Market capج.م3.12b
Earnings (TTM)ج.م173.98m
Revenue (TTM)ج.م2.99b

17.9x

P/E Ratio

1.0x

P/S Ratio

Is BIOC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOC income statement (TTM)
Revenueج.م2.99b
Cost of Revenueج.م2.06b
Gross Profitج.م933.94m
Other Expensesج.م759.96m
Earningsج.م173.98m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.08
Gross Margin31.23%
Net Profit Margin5.82%
Debt/Equity Ratio0%

How did BIOC perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

52%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/15 16:20
End of Day Share Price 2025/04/15 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

GlaxoSmithKline S.A.E is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.